Formed in 1998 by the families of children with primary immunodeficiency disorders (PID), IRIS ...

Formed in 1998 by the families of children with primary immunodeficiency disorders (PID), IRIS has nearly 500 members. IRIS disseminates information to health professionals and the public, supports the families of patients and research for new treatments, optimises access to care and works to improve the diagnosis rates of PID. Octapharma has helped IRIS create resources to help children understand how the immune system works  and helped with the FLEXIG app which enables people to better monitor their immunoglobulin treatment.

IRIS

Über uns

Plasma

Produkte

Karriere

Service